Top entities: Evotec, Nasdaq, Frankfurt Stock Exchange, European Union — Euro, Sarah Fakih.

What category does this event fall under?

Business — classified as earnings guidance.

What is the sentiment of coverage?

Aggregate sentiment score: -40 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This is an active story, last updated Jul 13, 2026. Coverage continues to evolve.

Business earnings guidance

Evotec lowers 2026 guidance

Q: When did this event occur?

First reported Jul 13, 2026; last updated Jul 13, 2026.

Q: What is the market impact?

General. The lowered guidance signals weaker-than-expected operational performance, likely pressuring Evotec's stock price.

Analysis based on 7 articles · First reported Jul 13, 2026 · Last updated Jul 13, 2026

Sentiment

-40

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The lowered guidance signals weaker-than-expected operational performance, likely pressuring Evotec's stock price. The biotech sector may see negative sentiment as investors reassess growth prospects.

biotechnology pharmaceutical

Event Summary

Evotec SE announced preliminary unaudited financial results for Q2 and H1 2026, reporting H1 revenues of approximately €300.1 million and adjusted EBITDA of -€42.7 million. The company lowered its full-year 2026 guidance: revenues now expected at €570-610 million (previously €700-780 million) and adjusted EBITDA at -€70 to -€105 million (previously €0-40 million). Liquidity as of June 30, 2026 was approximately €465.6 million. Full results will be published on August 13, 2026.

Key Actions

100 Evotec announced preliminary results

Entities Involved

stock

Evotec

Evotec is the subject of the announcement; its lowered revenue and EBITDA guidance indicate financial underperformance, negatively affecting investor confidence.

Importance 100.0 Sentiment -50.0

exch

Nasdaq

Evotec is listed on Nasdaq; the announcement may affect its stock price on this exchange.

Importance 10.0 Sentiment 0.0

exch

Frankfurt Stock Exchange

Evotec is listed on the Frankfurt Stock Exchange; the announcement may affect its stock price on this exchange.

Importance 10.0 Sentiment 0.0

curr

European Union — Euro

Financial figures are reported in euros; no direct impact on the currency.